Transitions between Oral Pharmacotherapies for Opioid Use Disorder

Presented by Dr. Neasa Coll

By the end of this BC ECHO on Substance Use session, participants will be able to:

1) Describe characteristics of pharmacotherapies for opioid use disorder (OUD) and evaluate whether a potential transition is appropriate for a given client

2) Describe how to safely and effectively transition a client between a partial agonist (buprenorphine/naloxone) and full agonists (methadone or slow-release oral morphine) buprenorphine/naloxone, methadone, and slow-release oral morphine, and

3) Describe how to safely and effectively transition a client between full agonists (methadone and slow-release oral morphine)